{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T23:50:35Z","timestamp":1790898635963,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA284591"],"award-info":[{"award-number":["R01CA284591"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RR190058"],"award-info":[{"award-number":["RR190058"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006808","name":"University of North Carolina","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006808","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100021763","name":"American Urological Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100021763","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Chemical Biology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.chembiol.2026.03.013","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T15:30:32Z","timestamp":1775575832000},"page":"461-473.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Selective degradation of TBK1 uncovers mechanistic insights into blocking ccRCC progression"],"prefix":"10.1016","volume":"33","author":[{"given":"Chengheng","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siying","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca L.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Gildor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shina","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noelle S.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey I.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianxin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6595-8995","authenticated-orcid":false,"given":"Qing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chembiol.2026.03.013_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.9","article-title":"Renal cell carcinoma","volume":"3","author":"Hsieh","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.chembiol.2026.03.013_bib2","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1158\/2159-8290.CD-11-0098","article-title":"Genetic and functional studies implicate HIF1\u03b1 as a 14q kidney cancer suppressor gene","volume":"1","author":"Shen","year":"2011","journal-title":"Cancer Discov."},{"key":"10.1016\/j.chembiol.2026.03.013_bib3","doi-asserted-by":"crossref","first-page":"E83","DOI":"10.1371\/journal.pbio.0000083","article-title":"Inhibition of HIF2alpha is sufficient to suppress pVHL-defective tumor growth","volume":"1","author":"Kondo","year":"2003","journal-title":"PLoS Biol."},{"key":"10.1016\/j.chembiol.2026.03.013_bib4","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ccr.2008.10.016","article-title":"HIF-alpha effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma","volume":"14","author":"Gordan","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.chembiol.2026.03.013_bib5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nature19795","article-title":"On-target efficacy of a HIF-2\u03b1 antagonist in preclinical kidney cancer models","volume":"539","author":"Cho","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2026.03.013_bib6","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature19796","article-title":"Targeting renal cell carcinoma with a HIF-2 antagonist","volume":"539","author":"Chen","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2026.03.013_bib7","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1056\/NEJMoa2103425","article-title":"Belzutifan for Renal Cell Carcinoma in von Hippel\u2013Lindau Disease","volume":"385","author":"Jonasch","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.chembiol.2026.03.013_bib8","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1158\/2159-8290.CD-19-0837","article-title":"TBK1 Is a Synthetic Lethal Target in Cancer with VHL Loss","volume":"10","author":"Hu","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.chembiol.2026.03.013_bib9","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s13046-022-02352-y","article-title":"The role of TBK1 in cancer pathogenesis and anticancer immunity","volume":"41","author":"Runde","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.chembiol.2026.03.013_bib10","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1080\/14728222.2020.1826929","article-title":"Targeting TANK-binding kinase 1 (TBK1) in cancer","volume":"24","author":"Revach","year":"2020","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.chembiol.2026.03.013_bib11","first-page":"531","article-title":"Emerging roles of TBK1 in cancer immunobiology","volume":"10","author":"Miranda","year":"2024","journal-title":"Trends Cancer"},{"key":"10.1016\/j.chembiol.2026.03.013_bib12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","article-title":"PROTAC targeted protein degraders: the past is prologue","volume":"21","author":"B\u00e9k\u00e9s","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.chembiol.2026.03.013_bib13","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.1039\/D2CS00193D","article-title":"PROTACs: past, present and future","volume":"51","author":"Li","year":"2022","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.chembiol.2026.03.013_bib14","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1021\/acs.jmedchem.7b00635","article-title":"Identification and Characterization of Von Hippel-Lindau-Recruiting Proteolysis Targeting Chimeras (PROTACs) of TANK-Binding Kinase 1","volume":"61","author":"Crew","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.chembiol.2026.03.013_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2021.707317","article-title":"E3 Ligase Ligands in Successful PROTACs: An Overview of Syntheses and Linker Attachment Points","volume":"9","author":"Bricelj","year":"2021","journal-title":"Front. Chem."},{"key":"10.1016\/j.chembiol.2026.03.013_bib16","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.38430","article-title":"Thalidomide promotes degradation of SALL4, a transcription factor implicated in Duane Radial Ray syndrome","volume":"7","author":"Donovan","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.chembiol.2026.03.013_bib17","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1182\/blood-2018-07-862953","article-title":"Bruton tyrosine kinase degradation as a therapeutic strategy for cancer","volume":"133","author":"Dobrovolsky","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.chembiol.2026.03.013_bib18","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.chembiol.2018.11.006","article-title":"Homolog-Selective Degradation as a Strategy to Probe the Function of CDK6 in AML","volume":"26","author":"Brand","year":"2019","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.chembiol.2026.03.013_bib19","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1158\/2159-8290.CD-17-0833","article-title":"Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids","volume":"8","author":"Jenkins","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.chembiol.2026.03.013_bib20","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1016\/j.drudis.2021.05.016","article-title":"TANK-binding kinase 1 (TBK1): An emerging therapeutic target for drug discovery","volume":"26","author":"Xiang","year":"2021","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.chembiol.2026.03.013_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/cells7090139","article-title":"Roles for the IKK-Related Kinases TBK1 and IKK\u03b5 in Cancer","volume":"7","author":"Durand","year":"2018","journal-title":"Cells"},{"key":"10.1016\/j.chembiol.2026.03.013_bib22","doi-asserted-by":"crossref","first-page":"D609","DOI":"10.1093\/nar\/gkae1010","article-title":"UniProt: the Universal Protein Knowledgebase in 2025","volume":"53","author":"Consortium","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.chembiol.2026.03.013_bib23","doi-asserted-by":"crossref","first-page":"14136","DOI":"10.1074\/jbc.M109.000414","article-title":"Use of the pharmacological inhibitor BX795 to study the regulation and physiological roles of TBK1 and IkappaB kinase epsilon: a distinct upstream kinase mediates Ser-172 phosphorylation and activation","volume":"284","author":"Clark","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.chembiol.2026.03.013_bib24","doi-asserted-by":"crossref","first-page":"7169","DOI":"10.1016\/j.bmcl.2012.09.063","article-title":"Synthesis and structure-activity relationships of a novel series of pyrimidines as potent inhibitors of TBK1\/IKK\u03b5 kinases","volume":"22","author":"McIver","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.chembiol.2026.03.013_bib25","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202303082","article-title":"NAK-associated protein 1\/NAP1 activates TBK1 to ensure accurate mitosis and cytokinesis","volume":"223","author":"Paul","year":"2024","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.chembiol.2026.03.013_bib26","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1038\/s41467-025-56955-y","article-title":"BBOX1 restrains TBK1-mTORC1 oncogenic signaling in clear cell renal cell carcinoma","volume":"16","author":"Liao","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chembiol.2026.03.013_bib27","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1021\/acsmedchemlett.9b00027","article-title":"Discovery of GSK8612, a Highly Selective and Potent TBK1 Inhibitor","volume":"10","author":"Thomson","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.chembiol.2026.03.013_bib28","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/nm1294","article-title":"Induction of interleukin-8 preserves the angiogenic response in HIF-1 alpha-deficient colon cancer cells","volume":"11","author":"Mizukami","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.chembiol.2026.03.013_bib29","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.1242\/jcs.02548","article-title":"Depletion of GAK\/auxilin 2 inhibits receptor-mediated endocytosis and recruitment of both clathrin and clathrin adaptors","volume":"118","author":"Lee","year":"2005","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.chembiol.2026.03.013_bib30","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1083\/jcb.200111068","article-title":"Phosphorylation of the AP2 \u03bc subunit by AAK1 mediates high affinity binding to membrane protein sorting signals","volume":"156","author":"Ricotta","year":"2002","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.chembiol.2026.03.013_bib31","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s13046-020-01672-1","article-title":"Proteolysis targeting chimeras (PROTACs) in cancer therapy","volume":"39","author":"Oca\u00f1a","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.chembiol.2026.03.013_bib32","doi-asserted-by":"crossref","first-page":"4476","DOI":"10.1039\/D0CC01485K","article-title":"PROTAC-mediated degradation of class I histone deacetylase enzymes in corepressor complexes","volume":"56","author":"Smalley","year":"2020","journal-title":"Chem. Commun."},{"key":"10.1016\/j.chembiol.2026.03.013_bib33","doi-asserted-by":"crossref","first-page":"12414","DOI":"10.1073\/pnas.1220674110","article-title":"Dissection of TBK1 signaling via phosphoproteomics in lung cancer cells","volume":"110","author":"Kim","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2026.03.013_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10072","article-title":"Tank binding kinase 1 is a centrosome-associated kinase necessary for microtubule dynamics and mitosis","volume":"6","author":"Pillai","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chembiol.2026.03.013_bib35","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1038\/s41556-018-0229-6","article-title":"TBK1 and IKK\u03b5 prevent TNF-induced cell death by RIPK1 phosphorylation","volume":"20","author":"Lafont","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.chembiol.2026.03.013_bib36","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ddtec.2019.01.002","article-title":"PROteolysis TArgeting Chimeras (PROTACs) - Past, present and future","volume":"31","author":"Pettersson","year":"2019","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.chembiol.2026.03.013_bib37","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature08460","article-title":"Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1","volume":"462","author":"Barbie","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2026.03.013_bib38","article-title":"Axl-mediated activation of TBK1 drives epithelial plasticity in pancreatic cancer","volume":"5","author":"Cruz","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.chembiol.2026.03.013_bib39","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41586-023-05704-6","article-title":"Targeting TBK1 to overcome resistance to cancer immunotherapy","volume":"615","author":"Sun","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2026.03.013_bib40","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1038\/s41556-018-0229-6","article-title":"TBK1 and IKKepsilon prevent TNF-induced cell death by RIPK1 phosphorylation","volume":"20","author":"Lafont","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.chembiol.2026.03.013_bib41","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1038\/s41556-019-0429-8","article-title":"TBKBP1 and TBK1 form a growth factor signalling axis mediating immunosuppression and tumourigenesis","volume":"21","author":"Zhu","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.chembiol.2026.03.013_bib42","article-title":"TANK-Binding Kinase 1 (TBK1) Serves as a Potential Target for Hepatocellular Carcinoma by Enhancing Tumor Immune Infiltration","volume":"12","author":"Jiang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.chembiol.2026.03.013_bib43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.15252\/embj.201696164","article-title":"The IKK-related kinase TBK1 activates mTORC1 directly in response to growth factors and innate immune agonists","volume":"37","author":"Bodur","year":"2018","journal-title":"EMBO J."},{"key":"10.1016\/j.chembiol.2026.03.013_bib44","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1128\/JVI.02705-14","article-title":"AP-2-associated protein kinase 1 and cyclin G-associated kinase regulate hepatitis C virus entry and are potential drug targets","volume":"89","author":"Neveu","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.chembiol.2026.03.013_bib45","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41568-023-00574-6","article-title":"Endocytosis in cancer and cancer therapy","volume":"23","author":"Banushi","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.chembiol.2026.03.013_bib46","doi-asserted-by":"crossref","first-page":"D543","DOI":"10.1093\/nar\/gkae1011","article-title":"The PRIDE database at 20 years: 2025 update","volume":"53","author":"Perez-Riverol","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.chembiol.2026.03.013_bib47","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.juro.2012.02.2573","article-title":"Age and gender related differences in renal cell carcinoma in a European cohort","volume":"188","author":"Hew","year":"2012","journal-title":"J. Urol."}],"container-title":["Cell Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451945626001054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451945626001054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T20:10:12Z","timestamp":1782418212000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451945626001054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2451945626001054"],"URL":"https:\/\/doi.org\/10.1016\/j.chembiol.2026.03.013","relation":{},"ISSN":["2451-9456"],"issn-type":[{"value":"2451-9456","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective degradation of TBK1 uncovers mechanistic insights into blocking ccRCC progression","name":"articletitle","label":"Article Title"},{"value":"Cell Chemical Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chembiol.2026.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}